AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
62 hedge funds and large institutions have $31.8M invested in Asterias Biotherapeutics Inc. Series A in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
58% less call options, than puts
Call options by funds: $241K | Put options by funds: $569K
Holders
62
Holding in Top 10
1
Calls
$241K
Puts
$569K
Top Buyers
| 1 | +$336K | |
| 2 | +$176K | |
| 3 | +$71.2K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$60K |
| 5 |
VF
Virtu Financial
New York
|
+$50K |
Top Sellers
| 1 | -$63K | |
| 2 | -$61.8K | |
| 3 | -$61K | |
| 4 |
SG Americas Securities
New York
|
-$57K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$34.7K |